Medical News

RSS

Exactech second quarter revenue increases 7% to $55.2 million

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $55.2 million for the second quarter of 2012, a 7% increase over $51.7 million in the second quarter of 2011.

31 Jul 2012

New Oxford University Press book on hypochondria

The "hypochondriac" is a complicated figure, often treated with scorn and derision, resented for making excessive demands on attention and health care resources.

31 Jul 2012

Obesity also affects sexual and urinary health in men

As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study, published in the August issue of the British Journal of Urology International (BJUI), is the first to comprehensively show that obesity in men affects not just their hearts and metabolism, but also their sexual and urinary health.

31 Jul 2012

Hyperion Therapeutics announces completion of initial public offering

Hyperion Therapeutics, Inc. announced today the completion of its initial public offering of 5,000,000 shares of common stock.

31 Jul 2012

Emergency Nurses Association praises NIH for new OECR

The following is a statement by Gail Lenehan, EdD, MSN, RN FAEN, FAAN, President of the Emergency Nurses Association, on the National Institutes of Health's New Office of Emergency Care Research: "As the national organization representing more than 40,000 emergency nurses, the Emergency Nurses Association (ENA) applauds the National Institutes of Health (NIH) for establishing the new Office of Emergency Care Research (OECR).

31 Jul 2012

Specific autoantibodies associated with blood vessel damage in the brain

The presence of specific autoantibodies of the immune system is associated with blood vessel damage in the brain. These findings were made by Marion Bimmler, a graduate engineer of medical laboratory diagnostics at the Max Delbr-ck Center for Molecular Medicine Berlin-Buch and Dr. Peter Karczewski of the biotech company E.R.D.E.-AAK-Diagnostik GmbH in studies on a rat model.

31 Jul 2012

Transcat first quarter net revenue decreases 2.0% to $25.1 million

Transcat, Inc., a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services, today reported financial results for its first quarter ended June 30, 2012.

31 Jul 2012

Bristol-Myers Squibb, Prosetta partner to discover and develop new antiviral drugs

Prosetta Antiviral Inc today announced the execution of a strategic alliance with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs.

31 Jul 2012

GE Healthcare, Intermountain partner to help reduce radiation dose in CT procedures by 50%

Intermountain Healthcare today announced a joint effort with GE Healthcare to help further reduce radiation dose in Computed Tomography (CT) procedures at its facilities by up to 50 percent.

31 Jul 2012

Oclaro fourth quarter revenues increase to $104.4 million

Oclaro, Inc., a provider of optical components, modules and subsystems, today announced the financial results for its fourth quarter and fiscal year 2012, which ended June 30, 2012.

31 Jul 2012

FDA clears Reflectance Medical's CareGuide Oximeter

Reflectance Medical, a commercial-stage company focused on the development of physiologic sensors to non-invasively and continuously assess patient metabolic status, announced today that it has received FDA 510(k) clearance for its initial product, the CareGuide Oximeter.

31 Jul 2012

NYGC purchases four Life Technologies' Ion Proton Sequencers

Life Technologies Corporation today announced that the New York Genome Center (NYGC) has purchased four Ion Proton Sequencers for its new Innovation Center.

31 Jul 2012

Life Technologies second quarter revenue increases 1% to $950 million

Life Technologies Corporation today announced results for its second quarter ended June 30, 2012.

31 Jul 2012

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

31 Jul 2012

Tips on how to keep children safe during extreme hot weather

Several US states and cities have seen record breaking temperatures this summer. Doctors at Cincinnati Children's Hospital Medical Center want to give tips to parents and guardians on how they can keep their kids safe during the hot weather.

31 Jul 2012

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision Incorporated today reported financial results for the quarter ended June 30, 2012.

31 Jul 2012

Registration now open for MedtechVision 2012 conference

MedtechWomen today announced that registration is now open for MedtechVision 2012: The Empowered Patient, the second annual conference designed by and for women on the forefront of medical innovation.

31 Jul 2012

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

InSite Vision Incorporated today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.

31 Jul 2012

Acadia second quarter revenue increases 58.1% to $100.5 million

Acadia Healthcare Company, Inc. today announced financial results for the second quarter ended June 30, 2012.

31 Jul 2012

Infuse Medical launches EtherDCP Mobile Application Management platform

Infuse Medical, a premier provider of mobile apps and content for the medical device market, today formally unveiled EtherDCP, an advanced Mobile Application Management (MAM) platform.

31 Jul 2012